Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease

BACKGROUND Nitric oxide (NO) plays an important role as an inflammatory mediator in the airways. Since chronic obstructive pulmonary disease (COPD) is characterised by airway inflammation, a study was undertaken to determine NO levels in the exhaled air of patients with COPD. METHODS Two groups of patients with clinically stable COPD were studied, 10 current smokers and 10 ex-smokers. Two control groups of healthy subjects consisting of 10 current smokers and 20 non-smokers were also studied. Exhaled NO levels were measured by the collection bag technique and NO chemiluminescence analyser. RESULTS Mean (SE) levels of exhaled NO in ex-smokers and current smokers with COPD (25.7 (3.0) ppb and 10.2 (1.4) ppb, respectively) were significantly higher than in non-smoker and current smoker control subjects (9.4 (0.8) ppb and 4.6 (0.4) ppb, respectively). In current smokers with COPD exhaled levels of NO were significantly lower than in ex-smokers. In this latter group of patients there was a significant negative correlation between smoking history (pack years) and levels of exhaled NO (r = –0.8, p = 0.002). A positive correlation was seen between forced expiratory volume in one second (FEV1) and levels of exhaled NO (r = 0.65, p = 0.001) in patients with COPD. CONCLUSIONS These data show that exhaled NO is increased in patients with stable COPD, both current and ex-smokers, compared with healthy control subjects.

[1]  W. Maziak,et al.  Exhaled nitric oxide in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[2]  BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease , 1997, Thorax.

[3]  P. Barnes,et al.  Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. , 1997, The European respiratory journal.

[4]  D. Yates,et al.  Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients. , 1997, The European respiratory journal.

[5]  M. Muers.  Overview of nebuliser treatment , 1997, Thorax.

[6]  S. Kharitonov,et al.  Exhaled and nasal nitric oxide measurements : recommendations , 1997 .

[7]  H. Makita,et al.  Production of nitric oxide (NO) in intrathoracic airways of normal humans. , 1996, American journal of respiratory and critical care medicine.

[8]  K. Hirata,et al.  Role of endogenous nitric oxide in airflow obstruction in smokers. , 1996, Chest.

[9]  S. V. Von Essen,et al.  Measurement of exhaled nitric oxide by three different techniques. , 1996, American journal of respiratory and critical care medicine.

[10]  P. Barnes,et al.  Exhaled nitric oxide: a new lung function test. , 1996, Thorax.

[11]  L. Fabbri,et al.  Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. , 1996, Thorax.

[12]  D. Yates,et al.  Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. , 1996, American journal of respiratory and critical care medicine.

[13]  P. Hedqvist,et al.  The promotion of patent airways and inhibition of antigen‐induced bronchial obstruction by endogenous nitric oxide , 1995, British journal of pharmacology.

[14]  D. Yates,et al.  Acute and chronic effects of cigarette smoking on exhaled nitric oxide. , 1995, American journal of respiratory and critical care medicine.

[15]  D M Hansell,et al.  Elevated levels of exhaled nitric oxide in bronchiectasis. , 1995, American journal of respiratory and critical care medicine.

[16]  P. Barnes,et al.  Nitric oxide and asthmatic inflammation. , 1995, Immunology today.

[17]  J. Stamler,et al.  The biology of nitrogen oxides in the airways. , 1994, American journal of respiratory and critical care medicine.

[18]  P. Barnes,et al.  Nitric oxide and lung disease. , 1993, Thorax.

[19]  E. Weitzberg,et al.  Increased amount of nitric oxide in exhaled air of asthmatics. , 1993, The European respiratory journal.

[20]  S Moncada,et al.  Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. , 1991, Biochemical and biophysical research communications.

[21]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[22]  S. Rennard,et al.  Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. , 1989, The American review of respiratory disease.

[23]  J. Hogg,et al.  Reassessment of inflammation of airways in chronic bronchitis. , 1985, British medical journal.

[24]  M. Cosio,et al.  Loss of alveolar attachments in smokers. A morphometric correlate of lung function impairment. , 1985, The American review of respiratory disease.